Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Cash Flow-to-Debt Ratio
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥15.48 Million could theoretically repay 0% of its total liabilities (CN¥2.17 Billion) in one year. Explore 002099 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Hisoar Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2024)
Historical debt coverage capacity for Zhejiang Hisoar Pharmaceutical Co Ltd across 22 annual periods. Also explore balance sheet size of Zhejiang Hisoar Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Year-by-year debt coverage analysis for Zhejiang Hisoar Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is Zhejiang Hisoar Pharmaceutical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | CN¥174.83 Million | CN¥2.32 Billion | ▼ -40.0% |
| 2023 | 0.13x | CN¥240.54 Million | CN¥1.92 Billion | ▲ +147.1% |
| 2022 | 0.05x | CN¥116.09 Million | CN¥2.29 Billion | ▼ -5.5% |
| 2021 | 0.05x | CN¥102.36 Million | CN¥1.91 Billion | ▼ -86.7% |
| 2020 | 0.40x | CN¥533.87 Million | CN¥1.33 Billion | ▼ -32.8% |
| 2019 | 0.60x | CN¥612.40 Million | CN¥1.02 Billion | ▲ +24.4% |
| 2018 | 0.48x | CN¥791.45 Million | CN¥1.64 Billion | ▲ +989.5% |
| 2017 | 0.04x | CN¥102.68 Million | CN¥2.32 Billion | ▼ -85.0% |
| 2016 | 0.29x | CN¥629.42 Million | CN¥2.14 Billion | ▼ -19.8% |
| 2015 | 0.37x | CN¥462.16 Million | CN¥1.26 Billion | ▲ +89.6% |
| 2014 | 0.19x | CN¥191.56 Million | CN¥988.73 Million | ▲ +370.2% |
| 2013 | 0.04x | CN¥60.85 Million | CN¥1.48 Billion | ▼ -73.1% |
| 2012 | 0.15x | CN¥180.73 Million | CN¥1.18 Billion | ▲ +15.5% |
| 2011 | 0.13x | CN¥92.62 Million | CN¥698.17 Million | ▼ -63.2% |
| 2010 | 0.36x | CN¥180.88 Million | CN¥502.28 Million | ▲ +59.0% |
| 2009 | 0.23x | CN¥98.38 Million | CN¥434.48 Million | ▲ +244.4% |
| 2008 | 0.07x | CN¥30.61 Million | CN¥465.58 Million | ▼ -47.1% |
| 2007 | 0.12x | CN¥51.14 Million | CN¥411.69 Million | ▼ -19.2% |
| 2006 | 0.15x | CN¥61.88 Million | CN¥402.66 Million | ▲ +67.8% |
| 2005 | 0.09x | CN¥36.07 Million | CN¥393.76 Million | ▼ -44.8% |
| 2004 | 0.17x | CN¥42.36 Million | CN¥255.35 Million | ▲ +943.5% |
| 2003 | -0.02x | CN¥-5.45 Million | CN¥277.36 Million | — |